If you’ve tried therapy or medication for PTSD and found yourself still struggling with symptoms, you’re far from alone—and it doesn’t mean you’re doing something wrong. Research shows that approximately 39% of people don’t respond adequately to first-line PTSD treatments, even when receiving guideline-recommended care (Semmlinger et al., 2024). This isn’t a personal failure or a sign that you’re “unfixable.” PTSD treatment response is influenced by a complex web of factors including symptom severity, co-occurring conditions, trauma type, demographics, and even the specific format of therapy you receive. Understanding why standard treatments haven’t worked for you is the first step toward finding an approach that will. Some people respond quickly to exposure therapy or SSRIs, while others need different interventions that target PTSD through alternative pathways. The goal isn’t to keep trying the same approaches harder—it’s to identify what’s preventing response and explore treatments better suited to your individual biology, history, and needs.
Treatment Resistance Is More Common Than You Think
When you hear about PTSD treatments having “strong evidence,” it’s easy to assume they work for everyone. The reality is more nuanced. Evidence-based treatments like Cognitive Processing Therapy (CPT), Prolonged Exposure (PE), and medications like sertraline or paroxetine work well at the group level—meaning they help the average person in research studies. But PTSD is not an average condition, and you are not an average patient.
Large-scale research reveals that even with the best current treatments, a substantial number of people continue experiencing clinically significant PTSD symptoms after completing therapy. This isn’t because the treatments are bad—they genuinely help many people. It’s because PTSD manifests so differently across individuals that a one-size-fits-all approach inevitably leaves some people without adequate relief.
If you’ve tried multiple treatments without success, you’re experiencing what clinicians call treatment-resistant PTSD. This doesn’t mean you can’t get better—it means you need a different approach. The question shifts from “Why am I failing at treatment?” to “Which factors are preventing my response, and what treatments might work differently for my specific situation?”
Baseline Symptom Severity Matters More Than You’d Expect
One of the strongest predictors of whether PTSD treatment will work is how severe your symptoms are when you start. Research consistently shows that people with higher PTSD symptom severity at baseline have worse treatment outcomes (Semmlinger et al., 2024; Maglione et al., 2022). This creates a difficult paradox: those who need help most urgently are often the ones for whom standard treatments are least effective.
Why does this happen? Severe PTSD often involves more complex symptom presentations, including dissociation, emotional numbing so profound it’s hard to engage emotionally in therapy, and hyperarousal so intense that it interferes with the learning processes therapy requires. When your nervous system is stuck in a state of constant threat, it’s difficult to engage in the reflective thinking that many therapies depend on.
If your PTSD symptoms are severe, standard outpatient therapy once a week may simply not provide enough structure or intensity to create change. Some people benefit from intensive outpatient programs, inpatient treatment, or interventions that work on stabilizing the nervous system before attempting trauma processing. Others may need medications or treatments that address the biological dysregulation before they can meaningfully engage in talk therapy.
When Depression Complicates Your PTSD Recovery
PTSD rarely travels alone. Many people with PTSD also experience depression, and this combination significantly impacts treatment response. Studies show that comorbid depression is associated with worse PTSD treatment outcomes (Semmlinger et al., 2024; Maglione et al., 2022). When depression is severe, it can create additional barriers—profound hopelessness that makes it hard to believe treatment will help, low energy that makes attending sessions difficult, or emotional numbness that prevents you from accessing the feelings therapy asks you to process.
The relationship between PTSD and depression is bidirectional. Sometimes trauma directly causes depression. Other times, the chronic stress of living with untreated PTSD gradually erodes mood. Depression can also make PTSD symptoms worse by increasing avoidance, disrupting sleep, and interfering with social support—all factors that normally help PTSD recovery.
If you have both PTSD and depression, integrated treatment addressing both conditions simultaneously tends to work better than treating them sequentially. Some newer approaches specifically target the overlapping mechanisms of both disorders. At Blossom Health & Wellness in Rapid City, we recognize that co-occurring depression often requires addressing underlying neurobiological patterns that affect both conditions—which is why treatments like ketamine infusion therapy, which works on shared glutamatergic pathways, can provide relief when standard approaches haven’t worked.
Military Service Changes the Treatment Response Equation
If you’re a veteran, your experience with PTSD treatment may differ from civilians in important ways. Research consistently demonstrates that military populations have poorer treatment outcomes compared to civilian trauma survivors, with worse PTSD remission rates even when receiving the same evidence-based therapies (Maglione et al., 2022). This isn’t about military personnel being somehow less capable of recovery—it’s about the nature of military trauma and the context surrounding it.
Combat-related PTSD often involves repeated trauma exposures, moral injury from impossible ethical dilemmas, loss of unit members who felt like family, and a transition back to civilian life that can feel profoundly isolating. The most significant predictor of poor treatment response in military populations is combat exposure itself—the more combat you experienced, the more difficult treatment tends to be (Maglione et al., 2022).
Military culture also affects treatment engagement. Values like self-reliance, toughness, and mission focus—essential in military service—can become barriers in therapy that requires vulnerability and emotional expression. Some veterans report that civilian therapists, while well-meaning, don’t fully understand military experience, which makes it harder to be open in sessions.
As a VA Community Care Network provider in Rapid City, Blossom Health & Wellness specifically serves veterans who haven’t responded to standard VA treatments. Understanding military culture and combat trauma isn’t just helpful—it’s essential for providing effective care to this population.
Individual Therapy vs. Group Therapy: Format Matters
The way treatment is delivered—not just what treatment you receive—significantly impacts your response. Research shows that individual therapy is associated with greater PTSD symptom improvement compared to group therapy (Maglione et al., 2022). This doesn’t mean group therapy is worthless—it provides valuable peer support and can be more accessible. But if you’ve only tried group therapy and haven’t seen improvement, switching to individual sessions might make a substantial difference.
Why does format matter? PTSD is deeply personal. Your trauma history, triggers, and coping patterns are unique. Individual therapy allows your clinician to tailor interventions precisely to your needs, adjust pacing based on your response, and create space for processing experiences you might not feel comfortable sharing in a group. Group therapy, while beneficial for reducing isolation and learning from others, necessarily moves at a pace that works for the group rather than for you specifically.
Length of treatment also matters significantly—it’s one of the strongest predictors of response (Maglione et al., 2022). Many people don’t receive enough treatment to see meaningful change. If you dropped out of therapy after a few sessions because you didn’t feel better immediately, you may have stopped before the intervention had time to work. PTSD treatment typically requires sustained engagement over weeks or months, not days.
Age, Gender, and Demographic Factors You Can’t Control
Some factors affecting treatment response are beyond your control but important to understand. Research reveals that older individuals and males are at greater risk of treatment nonresponse (Semmlinger et al., 2024). If you’re an older man with PTSD, you face statistical disadvantages in treatment response that have nothing to do with your effort or commitment.
Why might age affect response? Older adults may have lived with PTSD symptoms longer, creating more deeply entrenched patterns. They may also have more medical comorbidities, be on more medications that interact with psychiatric treatment, or face cognitive changes that affect learning new coping skills. Gender differences in treatment response may relate to biological factors, different trauma exposure patterns, or cultural influences on how men and women engage with therapy.
Refugee status is another significant predictor of treatment nonresponse (Semmlinger et al., 2024). Refugees often face ongoing stressors—uncertain immigration status, language barriers, discrimination, financial instability—that make it nearly impossible to focus on trauma processing when survival needs remain unmet. Cultural factors also play a role; Western therapy models may not align with how different cultures understand distress and healing.
Understanding these demographic factors isn’t about making excuses—it’s about recognizing that treatment needs to be adapted to your specific circumstances. A therapy approach that works for a young civilian woman with a single-incident trauma may need substantial modification for an older male refugee with chronic, complex trauma.
When Standard Treatments Aren’t Enough: Exploring Alternatives
If you’ve tried evidence-based PTSD treatments without success, what comes next? The encouraging news is that new treatment options are emerging specifically for treatment-resistant PTSD, targeting different biological mechanisms than traditional approaches.
Ketamine infusion therapy represents one such alternative. Unlike SSRIs that may take weeks to show effects and work through serotonin pathways, ketamine is an NMDA receptor antagonist that works on glutamatergic pathways in the brain. Research suggests ketamine holds promise as an effective treatment option for PTSD, particularly in treatment-resistant cases where remission rates with standard medications remain low at 20-30% (Almeida et al., 2024).
Ketamine appears to work partly by enhancing fear extinction—the brain’s process of learning that previously dangerous situations are now safe. In PTSD, fear extinction is impaired, which is why trauma memories remain so potent and triggers continue evoking intense reactions. By facilitating neuroplasticity and promoting the growth of new neural connections, ketamine may help the brain relearn safety in ways that traditional treatments don’t address.
Other emerging options for treatment-resistant PTSD include repetitive transcranial magnetic stimulation (rTMS), stellate ganglion block, intensive trauma-focused programs, and combination approaches that integrate medication with psychotherapy in coordinated ways. The key principle is matching treatment to the specific mechanisms maintaining your PTSD rather than assuming one approach works for everyone.
The Role of Physical Health in Mental Health Treatment
Something often overlooked in PTSD treatment is the state of your physical health. Better baseline physical health is associated with improved PTSD treatment response (Maglione et al., 2022). This makes sense when you consider that PTSD is fundamentally a mind-body condition—trauma affects not just your thoughts and emotions but your entire nervous system, immune function, hormonal balance, and inflammatory responses.
Chronic pain is particularly relevant. Many people with PTSD also experience persistent pain, and pain interferes with sleep, limits activity, increases irritability, and makes it harder to engage in therapy. If you’re managing both PTSD and chronic pain, addressing both conditions together tends to work better than treating them separately.
Sleep disturbances, substance use, and medical conditions all impact your capacity to benefit from PTSD treatment. If you’re not sleeping, if you’re using alcohol to manage symptoms, or if you have uncontrolled medical problems, even the best therapy will struggle to gain traction. This doesn’t mean you need to have perfect physical health before starting PTSD treatment—but it does mean that comprehensive treatment should address the whole person, not just psychological symptoms.
At Blossom Health & Wellness, we recognize this mind-body connection. Our approach to treatment-resistant PTSD includes attention to physical health factors, chronic pain management through ketamine infusion therapy, and coordination with other healthcare providers to ensure all aspects of your health support your recovery.
Social Support: The Hidden Treatment Ingredient
One factor that significantly predicts treatment success often gets less attention than it deserves: social support. Research consistently shows that people with stronger social support networks have better PTSD treatment outcomes (Maglione et al., 2022). This isn’t surprising—human connection is fundamental to healing from trauma. But if you’re socially isolated, it adds another barrier to recovery.
PTSD itself often damages relationships. Irritability pushes people away. Emotional numbing makes it hard to feel connected even when you’re with people you care about. Hypervigilance can make social situations exhausting. You may isolate yourself to avoid triggers or because you feel no one understands what you’re going through. This creates a vicious cycle: PTSD reduces social connection, lack of connection makes PTSD harder to treat, and poor treatment response reinforces isolation.
If you lack social support, addressing this limitation may need to be part of your treatment plan. This might mean joining a peer support group, rebuilding damaged relationships, or developing new connections. For veterans, connecting with other veterans who understand military culture and combat experience can be particularly valuable.
What You Can Do When Standard Treatments Haven’t Worked
Facing treatment resistance doesn’t mean accepting that you’ll struggle with PTSD forever. It means approaching the problem more strategically, with a clear-eyed assessment of factors that may be interfering with response and a willingness to try different approaches.
Get a comprehensive reassessment from a specialist in treatment-resistant PTSD. Not all providers have expertise in managing complex or treatment-resistant cases. A fresh evaluation might identify factors previous providers missed—undiagnosed comorbid conditions, trauma history elements that need different therapeutic approaches, or medical issues affecting treatment response. Document what you’ve already tried, what helped even slightly, and what made things worse. This information guides treatment planning.
Consider whether you’ve received adequate doses and duration of treatment. Many people try therapy briefly or take medications at doses too low to be effective. Evidence-based PTSD treatment typically requires sustained engagement—often 12-16 sessions minimum for trauma-focused therapies, and sometimes much longer. If you stopped treatment early because you didn’t see immediate improvement, you may not have given it enough time to work. Similarly, medication trials need to be at therapeutic doses for adequate duration before concluding they’re ineffective.
Explore innovative treatment options designed for treatment-resistant cases. If you’ve exhausted standard approaches, treatments like ketamine infusion therapy offer different mechanisms of action. Blossom Health & Wellness in Rapid City specializes in serving individuals who haven’t responded to conventional treatments. As a VA Community Care Network provider, we can work with veterans through VA referrals. For civilians, we offer consultation to determine whether innovative approaches might be appropriate for your situation. Contact us at 605-593-0560 to discuss your treatment history and explore options.
Moving Forward: Treatment Resistance Doesn’t Mean Hopelessness
The message that matters most is this: treatment nonresponse doesn’t reflect personal weakness, lack of effort, or being “broken beyond repair.” It reflects the complexity of PTSD and the reality that different people need different interventions. The 39% of people who don’t respond adequately to first-line treatments need second-line, third-line, or entirely novel approaches—not repeated attempts at the same interventions that haven’t worked.
Results vary by individual. What works brilliantly for one person may be ineffective for another, and that’s a feature of how diverse human biology and experience are, not a bug in the treatment system. Your path to recovery may be less straightforward than someone else’s, but that doesn’t make it impossible. It makes it yours—unique, requiring personalized solutions, and ultimately achievable with the right approach.
If you’re in the Rapid City area and you’ve been struggling with PTSD that hasn’t responded to standard treatments, know that specialized care is available. At Blossom Health & Wellness, we understand treatment resistance because we work with it every day. We offer comprehensive evaluation, innovative treatment approaches including ketamine infusion therapy, and the expertise to guide you toward interventions that address your specific barriers to recovery. You don’t have to keep trying the same approaches that haven’t worked. Contact us at 605-593-0560 to schedule a consultation and explore treatment options designed specifically for treatment-resistant PTSD.
References
Almeida, T. M., Lacerda da Silva, U. R., Pires, J. P., Borges, I. N., Martins, C. R. M., Cordeiro, Q., & Uchida, R. R. (2024). Effectiveness of ketamine for the treatment of post-traumatic stress disorder – A systematic review and meta-analysis. Clinical Neuropsychiatry, 21(1), 22-31. https://pmc.ncbi.nlm.nih.gov/articles/PMC10979792/
Maglione, M. A., Chen, C., Franco, M., Gizaw, M., Shahidinia, N., Baxi, S. M., & Hempel, S. (2022). Predictors of PTSD treatment retention and response: A systematic review. RAND Corporation. https://www.rand.org/pubs/research_reports/RR4191.html
Semmlinger, L., et al. (2024). Prevalence and predictors of nonresponse to psychological treatment for PTSD: A meta-analysis. Depression and Anxiety, 2024, 9899034. https://onlinelibrary.wiley.com/doi/10.1155/2024/9899034